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ABSTRACT
The thyroid hormone receptors (TRs) are transcription factors which activate or 
repress target genes in response to thyroid hormone. TR is synthesized in the cytoplasm, 
but must shuttle to the nucleus to assert its functions. Other nuclear receptors in this 
same superfamily have been shown to utilize some element of the cytoskeleton for 
directed transport from the cytoplasm to the nucleus, the site of action. Using 
mammalian cell transient transfection assays, the role of the cytoskeleton in subcellular 
trafficking of GFP-tagged (green fluorescent protein-tagged) TR and variants was 
investigated. Experiments presented in this thesis demonstrate for the first time a possible 
interaction between TR and the microtubules. This association was suggested by changes 
in receptor distributions upon disruption of the cytoskeleton through in situ fractionation 
or disrupting agents. Most strikingly, heterokaryon shuttling experiments show a 
dependence on microtubules for efficient shuttling of the receptor between the cytoplasm 
and the nucleus. Taken together these results suggest a requirement for intact 
microtubules for TR to traverse the expanse of the cytoplasm. This research helps to 
paint a more clear picture of the mechanism for nucleocytoplasmic shuttling o f TR.
vi
ROLE OF THE CYTOSKELETON IN NUCLEOCYTOPLASMIC SHUTTLING 
OF THE THYROID HORMONE RECEPTOR
2INTRODUCTION
The thyroid hormone receptor (TR) is a nuclear receptor for the thyroid 
hormone and acts as a transcription factor to activate or repress many genes. The 
pathway of thyroid hormone (T3) from its synthesis in the thyroid gland to its 
interaction with TR in target cells plays important roles in the regulation of growth 
and development. One aspect of regulation o f TR is its shuttling between the 
cytoplasm and the nucleus. Since TR is a transcription factor, it must enter the 
nucleus and bind to target DNA to affect transcription of T3 responsive genes. The 
means by which other nuclear receptors and transcription factors arrive at the nucleus 
has been investigated. Intriguing evidence suggests that elements of the cytoskeleton 
may be important for these proteins to traverse the expanse of the cytoplasm. This 
thesis research focuses on the mechanism by which TR travels through the cytoplasm 
to arrive at the nucleus. The following sections review the thyroid hormone 
receptors, their interaction with DNA, nucleocytoplasmic shuttling, and how elements 
of the cytoskeleton contribute to cytoplasmic travel of other proteins.
THYROID HORMONE
The thyroid hormones are important hormones in all vertebrates. Through 
interaction with its receptors, it regulates amphibian metamorphosis and mammalian 
reproduction, growth, development, neurodevelopment, and metabolism (Forrest et
3al, 2002; Schreiber et al, 2001). The mechanisms by which the thyroid hormone acts 
are specific to the species, tissues, and developmental phase involved.
In general, thyrotropin-releasing hormone (TRH) is secreted by the 
hypothalamus, which in turn stimulates secretion of thyroid stimulating hormone 
(TSH) by the anterior pituitary (Conn & Melmed, 1997) (FIGURE 1).
Approximately 10% of cells in the anterior pituitary are thyrotrophs, or TSH- 
secreting cells (Brook and Marshall, 2001). TSH secretion also follows a circadian 
rhythm, with maximum secretion near midnight, and minimum secretions at late 
afternoon (Conn & Melmed, 1997). TSH then induces the thyroid gland to secrete 
the thyroid hormones, thyroxin (T4) and triiodothyronine (T3) into circulation.
Thyroid hormone molecules are derived from modified tyrosine residues, in 
which iodine molecules have been attached (Brook and Marshall, 2001). This 
process is completely dependent on the supply of iodine to the gland to make 
hormone. Due to this dependence, the thyroid gland maintains a store of synthesized 
hormone within its follicles that may help to dampen the effects of changes in dietary 
iodine uptake. T3 has a half-life of approximately 1-3 days, while the half-life of T4 
is approximately 5-7 days.
Most thyroid hormone is bound to serum proteins while in circulation, and 
only a very small amount of hormone is in a “free” form (Brook and Marshall, 2001). 
It is only the “free” form of hormone that most cells respond to, and therefore much 
of the biologically active “free” T3 required for cellular activity is produced at the 
target tissue through local deiodination of T4. Because the thyroid hormone is lipid 
soluble, it can then pass freely through the cell membrane and into target cells,
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Figure 1. Thyroid Hormone Pathway. The hypothalamus releases TRH, which 
then stimulates the pituitary to release TSH. TSH binds to receptors on the thyroid 
gland, resulting in release of thyroid hormone. The thyroid hormone then inhibits 
further release of TRH and TSH through a negative feedback loop.
although it is believed that some cells may have a membrane transport mechanism 
specifically for the purpose of free thyroid hormone intake. One study found that a 
specific plasma membrane transport mechanism, system L, was important for T3 
entry into the cytoplasm (Ritchie et al., 2003). It is inside target cells where the T3 
interacts with TR. TSH and TRH are regulated by a negative feedback loop by the 
circulating thyroid hormone.
THYROID HORMONE RECEPTOR
There are two main forms of thyroid hormone receptors, TRa and TR(3 
(c-ErbA-1 and c-ErbA-2, respectively), which are encoded by two different genes. In 
humans the genes for TRa and TR|3 are on chromosomes 17 and 3, respectively 
(Laudet et al., 2002). TRa encodes the isoforms TRal and TRa2 which arise 
through alternative splicing. TRa2 cannot bind hormone but can still bind to DNA.
It therefore may block elements of the DNA where TR al induces gene expression, 
hence acting as a dominant negative inhibitor of T R a l. There are also two isoforms 
of TR)3 called TRp 1 and TRP2 which also arise through alternative splicing creating 
receptors which are the same in size, but differ in the tissues which express them.
The various forms of the thyroid hormone receptors carry some functional 
redundancy, although they do exert functions specific to a particular isoform and are 
sometimes expressed in different tissues at different stages in development (Gauthier 
et al., 1999).
The thyroid hormone receptor is a ligand-modulated transcription factor, and a 
member of the nuclear receptor superfamily. This superfamily includes receptors for
6retinoids, Vitamin D, and steroid hormones. TR specifically is classified as a Type II 
receptor, due to its ability to bind DNA with or without ligand (Tsai and OMalley,
1994).
All receptors in this superfamily have very similar structures. There are three 
main domains of TR (Conn & Melmed, 1997; Nelson et al., 1993) (FIGURE 2). The 
central domain is the DNA binding domain which is the most conserved domain 
within members of this receptor family. The DNA binding domain contains two zinc 
fingers of Cysteine-4 type. These zinc fingers interact with the major groove of DNA 
to stabilize the interaction (Brook and Marshall, 2001). It appears that the segment 
near the end of the first zinc finger, called the P box, is important for DNA binding 
specificity in most receptors in this superfamily (Laudet et al., 2002; Brook and 
Marshall, 2001). This area results in base pair recognition resulting in hydrogen 
bonds formed with DNA in the major groove. The second zinc finger associates with 
DNA via phosphate contacts. A portion at the beginning of the second zinc finger, 
called the D box, plays some role in this interaction. Portions of the DNA binding 
domain also play a role in dimerization.
There is an area between the DNA binding domain and the hormone binding 
domain that acts as a hinge and allows bending of the receptor (Laudet et al., 2002). 
The carboxyl terminal domain is responsible for ligand binding. This domain is a 
hydrophobic pocket, and when bound, the hormone is closed in by a “lid” and hidden 
inside the structure of the receptor (Laudet et al., 2002; Brook and Marshall, 2001). 
This ligand binding domain is also involved in dimerization, transactivation, and 
nuclear localization (Ribeiro et al., 2001). The N-terminal domain plays a role in
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Figure 2. Thyroid Hormone Receptor Domains. The activation domain (AD) is at 
the N-Terminus and plays a role in transcriptional activation. The DNA binding 
domain (DBD) contains two zinc fingers for interaction with DNA. The Ligand 
Binding domain (LBD) primarily serves to bind thyroid hormone.
transcriptional activation, and is not strongly conserved among members of the 
nuclear receptor superfamily.
DNA Binding
TR binds to DNA elements within the promoter or enhancer regions near 
target genes, called thyroid hormone response elements (TREs). TREs are six base 
pair sequences arranged as direct repeats, inverted repeats, or palindromes. The 
idealized hexameric sequence for TREs is generally 5’-AGGTCA (Conn & Melmed, 
1997; Forman et al., 1992; Nelson et al., 1993). A certain degree of regulation comes 
from the orientation and spacing between these hexameric sequences, and TREs seem 
more variable in sequence and spacing than other hormone response elements.
Certain TREs are more selective for monomers, homodimers, or specific 
heterodimers. TRa can bind to DNA as a monomer, or as a homodimer or 
heterodimer with the retinoid X receptor (RXR). TRp can bind to DNA only in the 
homodimer or heterodimer forms (Laudet et al., 2002). Direct repeats spaced by 4 
base pairs tend to bind TR/RXR heterodimers strongly, while inverted palindromes 
with 6 base pair spacing also bind homodimers (Ribeiro et al., 2001). In general, the 
TR/RXR heterodimer binds DNA with a higher affinity than the monomer or 
homodimer form. When T3 is present, it is predominantly the heterodimers that tend 
to stay associated with DNA.
9Coactivalors and Corepressors
TREs can be positive (pTRE) or negative (nTRE). The most understood and 
probably most abundant of the two is the pTRE. In this situation, unliganded TR 
(called the apo-form) generally represses transcription of target genes, whereas the 
ligand bound form (holo-form) causes activation of target genes (Laudet et al., 2002). 
The opposite is true for a nTRE where activation occurs in the absence of thyroid 
hormone, and repression occurs when ligand is bound.
In the situation of a pTRE, unliganded TRs have been shown to inhibit the 
assembly of the transcriptional preinitiation complex (PIC) which forms at the 
promotor of a pTRE to facilitate transcription (Tong et al., 1995; Tong et al., 1996; 
Baniahmed et al., 1993; Fondell et al., 1996). The C terminal region of both TRa 
and TRp have been shown to interact with many elements of the PIC including 
TATA-binding protein (TBP) and transcription factor IIB (TFIIB) alone, as well as 
TFIIB-TBP, TFIIA-TBP, and TFIIB-TFIIA-TBP complexes. It is believed that this 
interaction blocks the PIC from properly forming and initiating transcription from a 
TRE. When the thyroid hormone binds to the ligand binding domain of TR, this 
association is broken and the PIC can assemble unimpeded to activate transcription.
It is becoming increasingly clear that in addition to these interactions, TR 
must have help from corepressors and coactivators to effectively repress and activate 
target genes at a pTRE. Various corepressors such as N-CoR (nuclear receptor 
corepressor) and SMRT (silencing mediator for retinoid and thyroid hormone 
receptors) have been shown to interact with unliganded TR or with TR-RXR 
heterodimers. These corepressors inhibit transcriptional activation by recruiting
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histone deacetylases such as HDAC1 (Nagy et al., 1997). The histone deacetylase 
functions to make the DNA at the site of the target gene inaccessible through altering 
chromatin structure into a less open conformation. Upon thyroid hormone binding to 
TR, the corepressors dissociate from TR, and coactivators such as p300 can then bind 
to TR or TR-RXR. P300 possesses histone acetyltransferase activity (HAT), which 
may help to open up chromatin at the target gene to allow transcription to proceed 
(Ogryzko et al., 1996; Li et al., 1999). In fact, it has been shown that the HAT 
function of p300 is required for its ability to activate transcription through liganded 
TR-RXR heterocomplexes (Li et al., 2000). It has also been suggested that TR 
homodimers interact with corepressors such as SMRT to a higher degree than TR- 
RXR heterodimers, thus acting to repress transcription of target genes (Yoh and 
Privalsky, 2001). An additional level of regulation would arise from the TRE itself, 
as some TREs bind to homodimers or heterodimers more efficiently.
An opposite situation occurs at a negative TRE, where unliganded TR 
activates transcription, and TR with ligand bound represses transcription of target 
genes. The mechanism by which transactivation occurs at a nTRE is more poorly 
understood than that of a pTRE. Interestingly, in the absence of bound ligand, 
corepressors such as SMRT and N-CoR are still bound to the receptors at nTREs. It 
has been shown that mutating TR in a way to inhibit binding of SMRT and N-CoR 
leads to inhibition of transcriptional activation at nTREs (Berghagan et al., 2002). 
Using protease digestion combined with mobility shift assays, it has been 
demonstrated that TR -SM RT complexes have different conformations at nTREs than 
at pTREs. It is possible that the alternate conformation assumed by TR-SMRT at a
nTRE results in recruitment of a different set of proteins that then leads to 
transcriptional activation instead of repression.
There are many target genes of TR which possess TREs, including the genes 
for glycerol phosphate dehydrogenase, a-myosin heavy chain expression in cardiac 
muscle, TSH production, prestin protein, and sarcoplasmic reticulum CaATPase 
(Conn & Melmed, 1997; Brook and Marshall, 2001; Weber et al., 2002; Gauthier et 
al., 1999).
G121A: Mutant Form ofTR
In addition to the normal forms of TRa and TR|3, many mutant forms of TRs 
exist. v-erbA is a naturally occurring highly mutated homolog of TRa that is an 
oncogene carried by the avian erythroblastosis virus (AEV) (Laudet and Gronemeyer, 
2002.). There are also many mutated forms of the receptors in humans that lead to 
disease states, including generalized thyroid hormone resistance (Behr and Loos, 
1992).
In addition to these naturally occurring homologs and forms of TR, other 
mutant forms of human TRp have been created through site-directed mutagenesis in 
the laboratory (Nelson et al., 1993). One of these mutant forms, G121A, has an 
alanine substituted for a glycine at TRp amino acid position 121 (FIGURE 3). This 
substitution falls in the first DNA binding zinc finger of the DNA binding domain of 
TR, more specifically in the P box. An alanine was used in order to minimize the 
effect of the substitution on the a-helical structure of the DNA binding domain of TR.
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Figure 3. Zinc finger region of TRa. The DNA binding zinc finger domain of TR a 
contains two cysteine 4 type zinc fingers. The P box amino acids are circled, and the 
D box amino acids are boxed. The mutation in G 121A is at the glycine at position 
121 which in G121A is substituted by an alanine (Nelson et al., 1993).
Despite the substitution in the P box of the DNA binding domain, G121A can 
still bind DNA and can bind ligand, but it cannot transactivate target genes (Nelson et 
al., 1993). DNA binding was shown through gel shift assays with four different 
TREs to assess binding affinity. In only one case did G121A bind with any reduced 
affinity to the TRE. Activation of genes was assessed by cotransfection of COS 
(African green monkey kidney ) cells with G121A and TRE-linked CAT 
(cloramphenicol acetyl transferase) reporter plasmids. The inability of G121A to 
transactivate target genes suggests that this amino acid in the P box of TR plays some 
role in interaction with coactivators or corepressors important for transactivation.
Active transcription factors generally associate with the nuclear matrix, the 
fibrilogranular structure of the nucleus (Berezney and Jeon, 1995). T R a has been 
shown to associate with the nuclear matrix (Nicoll et al., 2003; Hollingshead, 2001). 
Since G121A is a transactivation mutant, it would not be expected to associate with 
the nuclear matrix. Therefore, G121A has a much more cytoplasmic distribution than 
normal TR, which has been shown in localization studies of G121A (Hollinghead, 
2001). This makes G121A particularly useful for studying cytoplasmic factors that 
affect normal TR. Another mutant form of TR, v-Erb A, has also been shown to have 
a more cytoplasmic localization than normal TR (Bunn et al. 2001). Given the 
cytoplasmic localization of mutant TRs, it is possible that mutant forms of the 
receptor such as G121A remain in locations within the cell, such as associated with 
the cytoskeleton in the cytoplasm, that the normal receptor passes through transiently 
on its way to the nucleus.
14
NUCLEOCYTOPLASMIC SHUTTLING OF TR
Nuclear Import o f  TR
Nuclear pore complexes (NPCs), are structures embedded in the nuclear 
envelope that act as a gateway for ions and molecules passing between the cytoplasm 
and the nucleus of a cell. NPCs are composed primarily of multiple copies of 
proteins called nucleoporins, which arrange to create an octagonal symmetry of the 
NPC including eight internal spokes (Rout et al., 2000; Gorlich and Kutay, 1999;
Rout and Aitchison, 2001). Within the structure is a central channel which serves as 
the actual transporter. Filaments create a basket-like structure on the nuclear side of 
the complex, while filaments on the cytoplasmic side of the NPC spread in many 
directions. Nucleoporins which make up the NPC are characterized by the presence 
of phenylalanine-glycine (FG) repeats (Rout and Aitchison, 2001; Ribbick and 
Gorlich, 2002;Ben-Efraim and Gerace, 2001). It is believed that these repeats are 
essential for facilitated transport to proceed, although the exact mechanism of passage 
through the central channel is still a matter of debate.
Three main models currently exist to explain the role of the FG repeats, and 
the actual process of translocation through the NPC. Ions and molecules of 20-40 
kDa can traverse the NPC by way of passive diffusion in theory, although most 
proteins enter by a facilitated pathway. Larger molecules must traverse the NPC by 
means of a facilitated transport pathway (Ribbick and Gorlich, 2002). Facilitated 
transport is mediated by several factors, the small GTPase Ran, RanGEF and 
RanGAP. RanGEF is found in high concentration in the nucleus, and RanGAP is
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found in high concentration on the cytoplasmic side of the NPC (Gorlich and Kutay, 
1999). Ran shuttles between the nucleus and the cytoplasm, and a gradient of forms 
of Ran exist between the two compartments. While on the cytoplasmic side of the 
nuclear membrane, Ran is found predominantly with GDP bound, and while on the 
nuclear side, is found with GTP bound. The conformation of Ran changes depending 
on which form it is in, allowing for Ran to interact with different effector proteins.
In the cytoplasm, cargo proteins which contain nuclear localization sequences 
(NLSs) bind to import proteins (importins), usually as a complex of importin a  and 
importin (3 (FIGURE 4). This complex enters the nucleus through the NPC (Gorlich 
and Kutay, 1999; Kaffman and O’Shea, 1999). Once in the nucleus, RanGTP binds 
to the import complex and causes it to release its cargo. The importin a  / importin (3 / 
RanGTP complex is then exported to the cytoplasm. In the cytoplasm, RanGAP 
removes the RanGTP from the importin complex, so that the importin can bind and 
carry new cargo into the nucleus. Hydrolysis of GTP occurs, thus maintaining the 
concentration gradient of RanGTP and RanGDP between the nucleus and cytoplasm.
Nuclear export utilizes a pathway involving similar mechanisms. For nuclear 
export, cargo has a nuclear export sequence which is recognized by an export protein 
(exportin). The cargo and exportin form a complex with RanGTP, which passes out 
of the nucleus through the NPC. In the cytoplasm, RanGAP causes the complex to 
dissociate, and exportin can re-enter the nucleus through the NPC.
Hydrolysis of GTP is not required for translocation of cargo through the NPC, 
dissociation of the cargo from the import complex, or export of the importin. GTP 
hydrolysis has been shown only to be necessary for maintaining the gradient of
16
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Figure 4. Nuclear Import Process. In the cytoplasm importins (I) attach to 
cargo (C) containing a nuclear localization sequence, and the complex enters the 
nucleus through the NPC. RanGTP binds to the complex in the nucleus releasing 
cargo. RanGTP/importin complex exits the nucleus, where RanGAP causes 
release of RanGTP and conversion to RanGDP.
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RanGTP and RanGDP across the nuclear membrane, thus allowing the importins and 
exportins to operate over and over again (Ribbeck et al, 1999).
The exact mechanism that TR utilizes to traverse the NPC is a current area of 
investigation in our laboratory (Bunn et al., 2001; Nicoll et al., 2003). Little research 
has been performed, however, on how TR reaches the NPC on the cytoplasmic side. 
TR could simply diffuse through the cytoplasm until it reaches the NPC, or there 
could be a mechanism that allows TR to take a more direct track towards the NPC, 
possibly via some element of the cytoskeleton.
Cytoskeleton and Protein Movement
The cytoskeleton is made up of protein fibers that perform functions in the 
cell such as motility, chromosome movement, establishing cell shape, and 
intracellular transport of organelles and proteins. The three main filaments of the 
cytoskeleton are actin filaments (microfilaments), intermediate filaments, and 
microtubules (Lodish et ah, 1995).
Actin filaments are the thinnest filaments at approximately 8 nm in diameter 
(Lodish et al., 1995). They specifically serve functions in mitosis, cytokinesis, cell 
locomotion, and interact with myosin in muscle contraction. There are two main 
forms of actin, F (filamentous) actin and G (globular) actin. G actin is a monomer, 
and these monomers polymerize to form F actin. Each actin molecule is complexed 
with a Mg2+ cation and with ATP or ADP. ATP hydrolysis leads to assembly of F 
actin.
Filamentous actin is a long flexible filament in which all actin monomers are 
arranged with the same polarity. The two ends of an actin filament are referred to as 
the pointed (-) and barbed (+) ends. Actin filaments elongate more rapidly at the (+) 
end than the (-)  end, although elongation does occur at both ends. Bundles of actin 
filaments, called stress fibers, run the length of the cell and are usually visible with 
light microscopy. The rest of the actin network is too small to be visualized with the 
light microscope.
Myosin is the main motor protein for actin. There are three main domains of 
a myosin protein, the head, neck, and tail regions (Lodish et al., 1995). The head 
region binds to actin and to ATP, the tail region contains various other binding sites, 
and the neck connects the head and tail regions and provides regulatory functions to 
affect binding of the head. The head region of myosin binds to actin and slides or 
walks along the filament.
The most characterized role of myosin is in muscle contraction. Additionally, 
myosins are thought to associate and disassociate rather quickly from actin filaments, 
and therefore be ill suited for cargo transport. Recently, however, some forms of 
myosin, specifically Myosin V and myosin IXb, have been shown to be processive 
motor proteins which could transport cargo directionally within the cell (Sakamoto et 
al., 2000; Inoue et al., 2002). Myosin V, a two-headed myosin, was shown to be a 
processive motor that moves cargo towards the barbed (+) end o f actin, and seems to 
stay associated with the filaments throughout the duration of the transport process 
(Sakamoto et al., 2000). Myosin IXb is a single headed myosin, and was shown to be
a minus-end directed processive motor protein, which also stays associated with the 
filaments for a long duration (Inoue et al., 2002).
Intermediate filaments (IF) are 10 nm in diameter and consist of five types of 
proteins (Lodish et al., 1995). These IF protein subunits are a-helix rods which then 
combine to make larger fibers. Their assembly is not dependent on GTP or ATP.
They are more stable than actin and microtubules, and play a more structural role in 
the cell in supporting cell and nuclear shape, and anchoring muscle cell filaments. 
They attach to the cellular and nuclear membranes to help provide structural rigidity. 
They do not seem to be essential for any types of movement within the cell, and 
motor proteins that associate with intermediate filaments have not been found. It is 
thought that intermediate filaments associate closely with the microtubule 
cytoskeleton, and the two networks sometimes have very similar distributions in the 
cell.
Microtubules are the largest cytoskeletal filaments at 24 nm in diameter, and 
are hollow cylinders (Lodish et al., 1995). They are composed of heterodimers 
containing one a-tubulin and one (3-tubulin monomer. The heterodimers arrange 
head to tail to produce protofilaments, which then assemble into a tubelike structure. 
Each monomer binds one GTP molecule, but only the (3-tubulin GTP is hydrolyzable. 
The microtubules are elongated and disassembled by addition or removal of dimers of 
a  and p tubulin, which is powered by GTP hydrolysis. At one end of a microtubule 
are only a-tubulin subunits, and at the other only p subunits. This arrangement 
produces a polarity, which is referred to by (+) and (-) ends. Assembly proceeds 
more quickly at the (+) end than the (-) end. Microtubules also radiate from specific
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sites of organization, called Microtuble Organizing Centers, or MTOCs (Lodish et al.,
1995). There are usually two MTOCs located near the nucleus. The assembly of 
microtubules originates at these centers, with the (-) ends at the MTOC and the (+) 
ends near the membrane of the cell.
Microtubules make up cilia and flagella, align chromosomes during meiosis 
and mitosis, and are also involved in intracellular movement (Lodish et al., 1995). 
One group of microtubule associated proteins (MAPs) serve as ATP-dependent 
motors to move along microtubules and transport vesicles, organelles, and proteins. 
Kinesin and dynein are two such motor MAPs that can move cargo directionally 
within the cell. Kinesin is usually a (+) end directed motor protein, delivering cargo 
near the periphery of the cell, and dynein is a (-) end directed motor protein, 
delivering cargo near the nucleus.
Cytoskeletal Dynamics
It is believed that cytoskeletal filaments work in concert as a network with 
constant communication and interaction to influence various aspects of cell 
movement, cell shape, and intracellular transport (Gavin, 1997). In addition to the 
overlapping distributions of microtubules and intermediate filaments, it appears that 
actin filaments and microtubules specifically interact in some manner as well (Yarm 
et al., 2001). It may be that there is a direct interaction through linker proteins, or it 
may just be that the two filament systems affect one another indirectly. There have 
been various putative linker proteins identified, although the scope of these 
interactions remains to be seen. It has also been shown that the two filament systems
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affect one another through regulatory factors. For instance, it has been shown that 
GEF-H1 (Rho guanine nucleotide exchange factor-FIl) affects actin polymerization 
based on changes in the microtubule cytoskeleton (Krendel et ah, 2002).
Intracellular transport of organelles and vesicles through the cytoplasm 
utilizing some portion of the cytoskeleton as a directed track is well characterized 
(Langford, 1995). More recently, there is evidence that proteins not associated with 
vesicles also can utilize this same cytoskeletal machinery for directed movement in 
the cell instead of relying on simple diffusion. Individual proteins can also use an 
element of the cytoskeleton as an anchor to maintain a cytoplasmic distribution until 
some other signal is produced to allow the protein to be released and move into the 
nucleus.
There are many examples of protein interactions with the cytoskeleton for the 
purpose of sequestration in the cytoplasm or for nucleocytoplasmic shuttling. A few 
examples of proteins which have been shown to have interactions for the purpose of 
sequestration are IkBcx, transcription factor MIZ-1, and Arabidopsis plant protein 
COP1 (Crepieux et al., 1997; Zieglebauer et al., 2001; and Matsui et al., 1995). 
Examples of proteins which have been shown to associate with the cytoskeleton for 
the purpose of nucleocytoplasmic shuttling are AE1 anion exchangers, autoimmune 
regulator protein (AIRE), chemokine receptors CXCR1 and CXCR2, and tumor 
suppressor p53, (Adair-Kirk et al., 2001; Pitkanen et al., 2001; Zaslaver et al., 2001; 
Giannakakou et al., 2002). In addition, there are other proteins for which an 
interaction with the cytoskeleton has been found which are closely related to thyroid 
hormone receptors. For example, the glucocorticoid receptor (GR), the Parathyroid
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hormone related protein (PTH-rp), and the Vitamin D receptor (VDR), interact with 
microtubules and seem to utilize the microtubule network for nucleocytoplasmic 
movement.
Glucocorticoid Receptor
Perhaps the most characterized and relevant example of protein movement 
along cytoskeletal filaments is the example of the glucocorticoid receptor (GR). GR 
is a member of the nuclear receptor superfamily along with TR, and shares many 
characteristics with TR.
When hormone is absent or at low levels, GR is mostly cytoplasmic. Upon 
addition of hormone, GR rapidly enters the nucleus, and is then able to shuttle back to 
the cytoplasm upon hormone withdrawal. It has been shown that this shuttling 
process is dependent on an intact cytoskeleton. More specifically, it is believed that 
the microtubules play a role in the directed motion of the GR in the cytoplasm 
(Galigniana et al., 1999; Galigniana et al., 2001; Galigniana et al., 1998). In 
addition, experiments have shown that under physiological conditions with an intact 
cytoskeleton, GR requires heat shock protein 90 (hsp90) to move from the cytoplasm 
to the nucleus (Galigniana et al., 1998). Heat shock proteins are known to directly 
interact with many nuclear receptors. The interaction of the heat shock protein and 
the receptor changes the conformation of the hormone binding domain of the receptor 
to increase its affinity for the hormone (Pratt and Toft, 1997).
A GR dephosphorylation event has also been shown to be a required step in 
the process of movement from the cytoplasm to the nucleus (Galigniana et al., 1999).
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GR-hsp90 heterocomplexes immunoadsorbed from cell cytosol, have been shown to 
also contain dynein and the immimophilin FKBP52. FKBP52 has been shown to bind 
to hsp90, GR, and dynein, and therefore may be the linker between GR-hsp90 
heterocomplex and the microtubule motor protein (Galigniana et al., 2001).
This information leads to a model where cytoplasmic GR, upon addition of 
hormone, translocates to the nucleus via movement through dynein on a microtubule 
track. It is believed that GR can also diffuse throughout the cytoplasm until reaching 
the NPC, however this mechanism appears to be secondary to the more directive 
transport in intact cells (Galigniana et al., 1998).
Parathyroid Hormone Related Protein
Another example of cytoskeletal dependent nucleocytoplasmic shuttling is the 
parathyroid hormone (PTH)-related protein. The N terminal domain of PTH-related 
protein is very similar to the actual parathyroid hormone (PTH), and both share many 
common functions and a common receptor (Lam et al., 2002). PTH-related protein 
was initially discovered due to its secretion by certain types of cancers, although it 
also plays roles in autocrine and paracrine functions
A green fluorescent protein (GFP)-tagged construct for PTH-related protein 
overexpressed in cells was shown to colocalize with microtubules (Lam et al., 2002). 
Studies using in vitro polymerized microtubules also showed association with PTH- 
related protein, and this interaction was enhanced with the addition of importin p 1. 
The use of nocodazole, a microtubule disruption drug, also inhibited 
nucleocytoplasmic shuttling, as demonstrated through fluorescence recovery after
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photobleaching (FRAP) experiments. These results indicate an important function of 
the microtubules in nucleocytoplasmic shuttling of PTH-related protein.
Vitamin D Receptor
It appears that the cytoskeleton plays a direct role in protein trafficking in the 
case of the Vitamin D receptor (VDR) as well. VDR is a member o f the nuclear 
receptor superfamily of transcription factors along with TR. VDR and 
l,25(OH)2D3, the active form of vitamin D, form a complex which interacts with 
vitamin D Response elements within target genes. It was once thought that VDR was 
only localized to the nucleus, but studies using fluorescent-tagged ligand to track 
VDR in living cultured cells, showed that VDR also localizes to the cytoplasm, 
specifically to ER, Golgi complexes, and microtubules (Barsony et al., 1997).
In light of the fact that VDR associates with microtubules, their role in import 
of VDR from the cytoplasm to nucleus was investigated (Kamimura et al., 1995). 
Using human monocytes and microtubule disrupting agents,it was found that for a 
normal response to vitamin D involving nuclear import of VDR, the microtubule 
network was necessary after vitamin D-VDR complex formation. These experiments 
showed that VDR may rely on the microtubules for nucleocytoplasmic shuttling, and 
this process could have widespread effects on gene regulation.
Question addressed in thesis
The fact that other nuclear receptors utilize an element of the cytoskeleton for 
directed movement in the cell leads to the question of whether the TR utilizes a
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similar mechanism. None of the TR literature thus far addresses this issue. This is 
possibly due to the more nuclear distributions of TR, which makes investigations into 
cytoplasmic localizations, and hence a cytoskeletal interaction, more difficult. Using 
fluorescent protein fusions of the two main forms of TR, as well as a transactivation 
mutant with a more cytoplasmic localization, this issue was investigated. GFP is a 
fluorescent protein derived from the jellyfish Aequorea victoria (Tsien, 1998). GFP 
along with other variants such as cyan fluorescent protein (CFP) and yellow 
fluorescent protein (YFP) provide an excellent way to tag and track proteins within 
live or fixed cells. The overall objective of this research was to provide insight into a 
step in regulation of TR that occurs before the receptor even enters the nucleus. 
Insight into this step of TR action will help to form an overall picture of thyroid 
hormone pathway function, and possibly a clearer picture of the mechanism of 
nucleocytoplasmic shuttling in general. In this research, three main questions were 
addressed.
1) Does TR colocalize with microtubules or actin filaments?
2) Does disruption of the microtubules or actin filaments affect TR localization?
3) Is shuttling of TR dependent on microtubules or actin filaments?
26
MATERIALS AND METHODS
PLASMIDS
Expression vectors for YFP fused to the N-terminus of human cytoplasmic (3- 
actin and to human a-tubulin were purchased from Clontech.
Expression vectors for GFP-G121A and GFP-TRp were subcloned by PCR 
into pEGFP-Cl (Clontech) by other members of Dr. Allison’s lab. G121A and TRp 
are fused to the C terminus of GFP. GFP-TRa was constructed as described (Bunn et 
al., 2001).
All GFP and YFP plasmids contain a kanamycin resistance gene which aids in 
their amplification and selection. Cloned gene constructs are under control of a 
cytomegalovirus (CMV) promoter.
All plasmids were amplified using Qiagen MIDI plasmid preparation kits.
This involved transformation of competent E . coli DH5a cells. First, 50 ng of 
plasmid DNA diluted in 10 pi of CaC12-Tris was added to 0.1 ml of D H 5a cells and 
incubated for 40 minutes. After the incubation, cells were heat shocked at 42°C for 2 
minutes. 0.4 ml LB (Luria Bertani) was then added to the mixture, and incubated for 
1 hour at 37°C (Sambrook and Russell, 2001). After the incubation, 0.1 ml of
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transformed bacteria were plated on pre-warmed LB-agar plates containing 
kanamycin at 30jig/ml. The plates were then grown overnight at 37°C.
From the plated bacteria, one colony was selected and added to 3 ml LB 
containing appropriate antibiotic. This starter culture was grown shaking at 37°C for 
approximately 8 hours to achieve logarithmic growth phase. 1 ml of the starter 
culture was then added to 100ml LB with appropriate antibiotic and grown shaking at 
37°C overnight. The plasmid DNA was then purified with plasmid MIDI prep kits 
according to the manufacturer’s protocol.
Subcloning o f  Plasmids
The CFP-G121A plasmid was constructed by subcloning G121A cDNA into 
pECFP-Cl (ClonTech Laboratories, Palo Alto, CA) as described below. Expression 
of G121A fused to the C terminus of CFP is controlled by the cytomegalovirus 
(CMV) promotor.
4 pg of pECFP-Cl and GFP-G121A were cut with the restriction enzyme 
E coR l. The digest was allowed to proceed at 37°C for 3 hours. Digested DNA was 
then purified with Qiagen PCR purification kits before the second digestion. DNA 
was then cut with the restriction enzyme BamHl at 37°C overnight. Following the 
second digestion, restriction digests were run on 1% agarose gels and stained with 
ethidium bromide at 1/10000 dilution to assure proper digestion and to separate 
fragments. The bands containing the pECFP vector and G121A insert were excised 
from the gel and purified with QIAquick gel extraction kit according to the 
manufacturer’s protocol. Vector and insert were then ligated using 3 units T4 DNA
28
ligase (Promega), overnight at 16°C . Insert:vector molar ratios of 3:1 and 1:1 were 
used. After the ligation, X L-10 Gold ultracompetant cells (Stratagene) were 
transformed with the plasmid construct and spread on LB/kanamyacin plates. Single 
colonies were then selected for culturing and plasmid isolation as described earlier.
CELL CULTURE
NIH Swiss Mouse embryo fibroblast (NIH-3T3) cells were cultured and 
maintained in DMEM ( Dulbecco’s Modified Eagle’s Medium) (Gibco) with 10% 
calf serum, supplemented with penicillin (lOOU/ml) and streptomycin (lOOpg/ml). 
HeLa cells were maintained in MEM (Minimal Essential Medium) (Gibco) with 10% 
Fetal Bovine Serum, supplemented with penicillin and streptomycin. All cells were 
kept in a 37° C incubator at 98% humidity and 5% CCA
Transfections
Cells were seeded at approximately 0.15-0.2 x 105 cells per well in 0.5 ml 
DMEM without antibiotics into 4 well chamber slides (LabTek) approximately 24 
hours prior to transfection. Transient transfections were then performed by the 
liposome-complex formation method. 2 pg of plasmid DNA was mixed with 10 pi 
LipofectAmine reagent (Gibco BRL) in Opti-MEM I reduced serum media (Gibco) 
for a total volume o f 200 pi, and incubated at room temperature for 20 min. After the 
incubation period, 200 pi of the liposome-complex mixture was combined with an 
additional 100 pi Opti-MEM and 200 pi DMEM for a total volume of 500 pi.
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Complete media was aspirated off cells, and the transfection medium was added.
Cells were incubated at 37° C for approximately 24 hours.
For cytochalasin D (Sigma) and colchicine (Sigma) experiments, prior to 
fixation, transfection medium was aspirated off and replaced with DMEM alone for 
no treatment controls, DMEM with the corresponding volume of DMSO for vehicle 
controls, and DMEM with varying concentrations of cytochalasin D (5-15 pM) or 
colchicine (30 pM) dissolved in DMSO for drug treatment groups. Cells were 
returned to the incubator for 1 hour and then fixed as described under whole cell 
fixations, except that the cells were not maintained on ice.
In Situ Extractions
After 24 hours incubation, media was aspirated off, and chamber slides placed 
on ice. Cells were washed in ice-cold D-PBS 3 times for 15 seconds. Procedures 
follow those in Cells: A Laboratory Manual (Spector et al., 1998).
Whole Cell: Following the D-PBS wash, cells were fixed with 3.7% formaldehyde 
in D-PBS for 10 minutes. The cells were then washed 3 times in D-PBS for 5 
minutes. Cells were then permeabilized with 0.2% Triton-X-100 in D-PBS for 5 
minutes. Finally, cells were washed 3 times in D-PBS for 5 minutes each. Cells were 
kept on ice for all steps until formaldehyde fixation.
Cytoskeletal Fixation: Following initial D-PBS wash, cells were washed three times 
for 5 minutes each in 0.5 ml ice cold Cytoskeleton Buffer (lOmM PIPES, 0.1 M 
NaCl, 3 mM MgCh, 1 mM EGTA, 300mM sucrose, 0.5% Triton-X-100, 12 mM 
PMSF) with VRC (Vanadyl Ribonucleoside Complex) at 2mM. VRC is used to
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inhibit RNA degradation. Cells were then fixed for 10 minutes with 0.5 ml of 3.7% 
formaldehyde in Cytoskeleton Buffer without VRC at room temperature. After 
fixation, cells were washed three times with 0.5 ml D-PBS for five minutes each. All 
steps were performed on ice prior to formaldehyde fixation. This extraction 
procedure should remove all soluble components in the cell, and minimally affect the 
cytoskeleton.
Nuclear Matrix-Intermediate Filament Fixation: Following initial D-PBS washes, 
cells were washed three times for 3-5 minutes in 0.5 ml Cytoskeleton Buffer with 
VRC. Cells were then washed two times in 0.5 ml Extraction Buffer (lOmM PIPES, 
3mM MgCl2, ImM EGTA, 300mM sucrose, 250mM ammonium sulfate, 12 mM 
PMSF) with 2mM VRC for 3-5 minutes. Cells were then incubated in 0.5 ml 
Digestion Buffer (lOmM PIPES, 50mM NaCl, 3mM MgCl2, ImM EGTA, 300mM 
sucrose, 200-400units DNase per ml (Epicentre), 0.5% Triton-X-100, 12 mM PMSF, 
20mM VRC) at room temperature with gentle agitation. After 30-50 minutes 
incubation, cells were washed in Extraction Buffer two times for 5 minutes. Cells 
were then fixed in 3.7% formaldehyde in Digestion Buffer (without DNase or VRC) 
for 10 minutes at room temperature. Finally, cells were washed in 0.5 ml D-PBS two 
times for 5minutes. All steps prior to formaldehyde fixation were performed on ice. 
After fixation, all soluble components of the cell should be removed, including most 
of the tubulin and actin cytoskeleton. The main elements remaining are the more 
stable intermediate filaments and the nuclear matrix.
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Following each extraction and fixation procedure, all slides were mounted in 
Vectashield with DAPI (Vector labs). Coverslips were sealed with nail polish and 
kept in the dark at 4°C until viewing with a fluorescence microscope.
HETEROKARYONS
Heterokaryon experiments were performed following a well established 
method ( Spector et al., 1998). 2 ml of NIH3T3 cells were plated on sterile glass 
coverslips in 6-well plates (Nunc) at approximately 1 X 105 cells per well. 
Approximately 24 hours after plating, cells were transfected with GFP-TRa 
expression vector using the liposome complex formation method. For each well, 2 pg 
plasmid was diluted to 100 pi with Opti-MEM, and 10 pi LipofectAmine was added 
to 90 pi Opti-MEM. The two solutions were then combined and left to incubate at 
room temperature for 15 minutes. During this incubation, cells in the 6-well plates 
were rinsed in 2 ml of Opti-MEM. Subsequently, 800 pi Opti-MEM was added to the 
liposome plasmid mixture, mixed, and added to the plated cells for 1 ml total per 
well.
Approximately 16 hours after transfection, HeLa cells were added to the 
mouse cells. This was done by resuspending HeLa cells in Heterokaryon Growth 
Medium (70% DMEM, 10% FBS, 20% sterile ddH20), and plating them at a 
concentration of approximately 7 X 103 cells per well onto the NIH3T3 cells which 
had been rinsed in Heterokaryon Growth Medium. 10 pi of lOmg/ml cycloheximide 
(Sigma) for a final concentration of 50 pg/ml was added to each well to prevent new 
protein synthesis. The cells were then incubated for 2.5 hours at 37°C. After the
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incubation, medium was replaced with 2 ml pre-warmed D-PBS, and then repeated to 
rinse the cells. Coverslips were then placed cell side down on a lOOpl drop of pre­
warmed 50% polyethylene glycol (PEG) 1500 (Roche Diagnostics) on parafilm to 
allow for cell fusion. Coverslips were allowed to remain on the PEG for exactly 2 
minutes. During this step, fresh D-PBS was added to each well. After the 2 minute 
incubation, coverslips were returned to the 6 well plate, cell side up. After washing 
15 seconds, fresh D-PBS was added to the wells. Next, the D-PBS was aspirated off, 
and 2 ml Heterokaryon Growth Medium with 100 pg/ml cycloheximide was added.
In vehicle and drug treatment slides, colchicine or cytochalasin-D in DMSO, or an 
equivalent volume of DMSO alone was added to each well at this time. Cells were 
then incubated for 1 hour to allow shuttling to occur.
Following the incubation, cells were fixed. This was done by rinsing cells 3 
times in D-PBS for 15 seconds each wash. Cells were then fixed in 3.7% 
formaldehyde for 10 minutes. Cells were then rinsed 3 times again in D-PBS for 5 
minutes each wash. Cells were then permeabilized in 0.2% Triton-X-100 in D-PBS 
for 5 minutes. Finally, cells were rinsed 3 times in D-PBS for 5 minutes each wash. 
To stain the DNA, 1 ml or 10 jag/ml Hoechst 33258 dye in D-PBS was added to the 
wells for 20 minutes in the dark. Cells were then washed 3 times in D-PBS for 15 
seconds each wash. Coverslips were mounted in Vectashield and sealed with nail 
polish. Slides were then stored at 4°C until viewing.
FLUORESCENCE MICROSCOPY
All slides were viewed on an Olympus Fluorescence Microscope. A FITC 
filter (NB) was used to visualize GFP fluorescence, and the UV filter (NU) was used 
for viewing DAPI fluorescence. Photographs were taken of selected cells using a 
Cooke Sensi Cam High Performance Digital Camera. Images were stored and 
pseudocolored using Iplab software for IBM and Macintosh computers.
For each experiment with NIH3T3 cells, 3 trials of each experiment were 
performed. At least 100 cells for each treatment of each trial were counted. The only 
exceptions were for experiments dealing with cytoskeletal disruption, including the 
Cytoskeletal and Nuclear Matrix Intermediate Filament fixations, where too many 
cells had lost adhesion to substrate due to loss of the cytoskeleton, and counting 100 
cells was not possible. In these cases, as many cells were counted as possible for 3 
separate trials.
For GFP-TRa, GFP-TRp, and GFP-G121A experiments, cells were scored 
qualitatively according to their distributions. Initially, a score of 0 through 4 was 
assigned to each cell counted: 0, entirely cytoplasmic distribution; 1, distribution 
throughout the cell, but with greater fluorescence in the cytoplasm; 2, even whole 
cell distribution; 3, whole cell distribution with greater fluorescence in the nucleus; 4, 
completely nuclear distribution. Cells were also categorized as having foci or no foci 
in each category. For graphical representation and statistical analysis, cells were then 
grouped according to larger categories, because some categories were irrelevant or 
insignificant for the experiment at hand.
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For heterokaryon experiments, at least 20 heterokaryons were counted from 
various numbers of trials. It was possible to distinguish NIH-3T3 nuclei from HeLa 
nuclei due to their differential staining with the Hoescht DNA stain. NIH-3T3 nuclei 
appear spotted or punctuate, while HeLa nuclei appear diffuse (Bunn et al., 2001). In 
some cases where justified, such as when no shuttling was observed, homokaryons 
were also counted along with heterokaryons. Heterokaryons were classified as non­
shuttling, shuttling with uneven fluorescence in the nuclei, and shuttling with even 
fluorescence in the nuclei.
All cells counts were performed blind, without prior knowledge of the 
treatment. The counts for each experiment type were also performed within 2 days of 
one another to avoid differences in appearance of cell fluorescence due to the age of 
the mercury bulb, or to slight variations in classifications into the specific categories.
STATISTICAL TESTING
Once cells were counted, results were tested for statistical significance using 
SAS statistical software. A log-linear analysis with no three variable interaction was 
performed on each data set. This resulted in a p value and a likelihood ratio for each 
experiment. A p value of p<0.01 was considered significant, while anything greater 
than this value was not considered significant. A likelihood ratio of greater than 0.05 
indicated that results were likely due to the treatment and not due to errors related to 
the various trials. Liklihood ratios were not available for a few experiments due to 
the uneven numbers of cells counted in those trials.
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RESULTS
DISRUPTION OF CYTOSKELETON EFFECTS TR LOCALIZATION
The first set of experiments that was performed was aimed at determining if 
disruption of the cytoskeleton had an effect on the subcellular distribution of TR. If 
disruption of the cytoskeleton did effect receptor localization, this could indicate an 
association between an element of the cytoskeleton and the receptor. To do this, 
NIH3T3 (mouse) cells were first transfected with a variety of fluorescent protein-TR 
fusions and then, approximately 24 hours post transfection, a series o f extractions 
were performed to remove elements of the cytoskeleton from the cells. For analysis 
of intact, whole cells (WC), some samples were fixed immediately. Cytoskeletal 
(CSK) extractions used salt and detergents to remove the soluble components of the 
cells. This extraction should remove all soluble components of the cell, and leave the 
cytoskeleton undisturbed (Spector et al., 1998). Finally, the Nuclear Matrix- 
Intermediate Filament (NM-IF) extraction used DNase, salts, detergents, and 
ammonium sulfate to extract most of the microtubules, actin filaments, DNA, and 
residual soluble components of the cell, leaving the nuclear matrix and the more 
stable intermediate filaments undisturbed. If NMIF fractionation is complete, then 
the DNA should be digested by DNase and nuclear staining by DAPI should be 
absent or barely visible. Two alternative protocols for these in situ fractionations
36
were tested. In order to verify that the NM-IF extraction procedure was, in fact, 
removing the majority of microtubules and actin filaments, and that the CSK 
procedure was affecting the cytoskeleton to a lesser degree, control experiments were 
performed. NIH3T3 cell were transiently transfected with expression vectors for 
YFP-actin or YFP-tubulin. Approximately 24 hours post transfection, these cells 
were then subjected to the three fixation procedures. Distribution patterns and percent 
expression were recorded for each slide (Appendix).
YFP-actin in unfractionated, whole cells (WC) had three main types of 
distributions. In some cells, approximately 69%, the YFP-actin was diffuse 
throughout the entire cell (Figure 5; Figure 6). In approximately 12% of cells, the 
distribution of YFP-actin was more punctate, containing aggregates or foci in the 
cytoplasm. In approximately 19% of cells, full filaments or stress fibers were visible. 
Pilot studies indicated that the distributions changed slightly depending on how long 
the cells were incubated after transfection and before fixation. The longer the cells 
were incubated, the more cells with visible stress fibers were observed. This is 
probably due to more of the expressed YFP-actin being incorporated into the larger 
stress fibers. Thus, for consistency in subsequent experiments, in all slides that were 
scored, the cells were fixed 24 hours post transfection.
In WC fixation slides, approximately 13% of all cells fluoresced indicating 
YFP-actin expression, and retention during fixation (Figure 7). This is a low 
transfection efficiency, but was consistent among trials. In the CSK fixations, YFP- 
actin was detectible in only 6% o f cells indicating that this extraction removed some 
of the actin cytoskeleton. The number o f cells with detectable YFP-actin was reduced
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Figure 5. Intracellular distribution patterns of Y FP-actin and YFP-tubulin. Normal 
WC distribution of YFP-actin ranges from diffuse ( la), to filament/stress fibers visible (lb ), 
to a punctate distribution with cytoplasmic foci (2a.2b). YFP-tubulin distributions are 
generally diffuse in the cell, either with a whole cell distribution (3a) or mostly cytoplasmic
(3b).
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filaments/stress fibers diffuse punctate/foci
Figure 6. Normal distributions of YFP-tubulin and YFP-actin. YFP-tubulin has 
normal distributions of throughout the entire cell in approximately 27% of cells and 
only cytoplasmic distribution in approximately 73% of cells (6A). YFP-actin has 
normal distributions of filaments/stress fibers in 19% of cells, diffuse distribution in 
69% of cells, and punctate/foci distribution in 12% of cells (6B).
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Figure 7. Summary of the effects of WC, CSK, and NMIF extractions on YFP-
tubulin and YFP-actin. NMIF extraction procedure causes number of cells 
expressing YFP-tubulin (7A) and YFP-actin (7B) to decrease due to removal of the 
actin and tubulin cytoskeleton in this procedure.
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to 0.8% with the NM-IF fixations, indicating that most of the actin cytoskeleton was 
extracted, as expected. On the NMIF slides, DAPI staining of the nucleus was also 
extremely attenuated, indicating effective digestion of DNA during the procedure.
In the CSK and NM-IF fixations, the intracellular distribution pattern of YFP- 
actin also changed somewhat, with more cells having cytoplasmic foci in the NM-IF 
samples. However, because the results were highly variable, and sample sizes were 
low, the changes in distribution between the WC, CSK, and NM-IF fixations gave 
significant p values, but had very low likelihood rations (p<0.0001, LR=0.0006).
YFP-tubulin had only two WC distributions that were easily categorized.
These were diffuse throughout the entire cell, and diffuse but mostly cytoplasmic 
(Figure 5). In the WC fixation experiments, approximately 27% of transfected cells 
scored showed whole cell distributions, while 73% of cells had mostly cytoplasmic 
distributions. This did not change much in CSK fixations or NM-IF fixations. These 
results gave significant p values but the actual data were highly variable (p=0.0003, 
LR=0.1149), and once again may be skewed due to the low sample size resulting 
from very few cells expressing YFP-tubulin in the NM-IF experiments.
In the WC fixations, approximate YFP-tubulin expression and presence was 
noted in 40% of cells (Figure 7). This transfection efficiency was much higher than 
for that of YFP-actin. In CSK fixations this dropped to 11%. In NM-IF fixations, 
only 2% of cells still showed YFP-tubulin expression. This difference was significant 
(p<0.0001, LR=0.1695) and demonstrated that the NM-IF fixation did, in fact, extract 
most of the microtubule cytoskeleton as anticipated. Once again, DAPI staining of 
the nucleus was greatly reduced, indicating removal of most of the DNA.
Using one protocol (Fey and Penman, 1988), the NM-IF fixations did not 
remove most of the microtubules or actin filaments. The most effective fixation 
protocol of this type and the protocol followed for the remainder of experiments was 
adapted from Cells: A Laboratory Manual (Spector et al., 1998).
After the efficiency of the fixation procedures was established, experiments 
were performed to investigate the effect of loss of cytoskeletal components on TR 
and variants. If the receptors were associating with an element of the cytoskeleton for 
the purpose of nucleocytoplasmic transport, it is possible that removal of the 
cytoskeletal component would result in loss of the receptor during the extraction 
procedure, or a change in receptor subcellular localization. If the receptor was not 
associated with the cytoskeleton or the nuclear matrix, the receptor would be entirely 
removed with the soluble fraction during the CSK extraction.
GFP-G121A distribution shifts to more cytoplasmic upon cytoskeleton disruption
The first receptor studied was GFP-G121 A. G121A is an in vitro generated 
transactivation mutant of TR(3. This receptor has a more cytoplasmic localization 
than normal TR. GFP-TRa is almost completely nuclear is its localization pattern 
with fluorescence microscopy, although it has been shown to shuttle rapidly between 
the cytoplasm and the nucleus (Bunn et al., 2001)(Figure8, panel 1). GFP-TRp is 
more varied in its localization pattern, but still has a more nuclear distribution (Figure 
8, panel 2). There is a more cytoplasmic localization of GFP-G121A, and the 
distributions of GFP-G121A vary widely cell to cell. Some cells exhibit diffuse 
whole cell localization, some have cytoplasmic foci, and some have a perinuclear
42
GFP DAPI
GFP-TRcc
G FP-T R p
G F P -G 121A
G F P -G 121A
5a 5b
G F P -G 121A
Figure 8. Normal distributions o f  GFP-TRcc, GFP-TRp,and GFP-G121 A. G FP- 
TRcc has an alm ost entirely nuclear distribution ( lab), w hile TRP has a m ore 
cytoplasm ic portion (2 a b ) . G FP-G  121A has a w ide range o f  distributions, from 
cytoplasm ic foci (3ab), to diffuse w hole cell (4 a b ) , to perinuclear. (5ab)
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distribution (Figure 8, panels 3-5). An entire spectrum of distributions exists between 
these distributions as well. Due to this more cytoplasmic localization of GFP-G121A 
compared with TRa and TR|3, it therefore may show the most dramatic change if an 
association with the cytoskeleton does exist.
For the purpose of consistency in tabulating data, a categorization system was 
established for all receptors. A ranking of 0 through 4 was assigned to each cell, and 
then grouped according to being a diffuse distribution, or a punctate distribution (see 
Materials and Methods) (Figure 9). After all cell counts were made, the results from 
each of these groups were combined into appropriate larger groups, depending on the 
receptor studied for the purpose of statistical analysis. In the case of the WC, CSK, 
and NMIF experiments, results for a distribution score of 4 and 3 were grouped 
together as “more nuclear”, while scores of 2,1,and 0 were grouped together as “even 
(whole cell) or cytoplasmic” distributions. Comparing CSK and NMIF fixations, 
there was a significant change in distribution of GFP-G121A (p<0.0001) (Figure 10). 
In WC fixations, approximately 58% of cells exhibited an even/cytoplasmic 
distribution, while almost all cells in CSK and NMIF fixations exhibited this 
distribution. Also, the percentage of cells exhibiting a punctate distribution was 
approximately 26% for WC fixations. This percentage rose dramatically in CSK and 
NMIF fixations with 86% of cells with punctate distributions of GFP-G121A in CSK 
fixations and 92% of cells with punctate distributions in NMIF fixations (Figure 10). 
These data display a significant difference where removal of the cytoskeleton results 
in a more cytoplasmic and more punctate distribution for the localization of GFP- 
G121A.
44
GFP DAPI
d is t  sc o r e  
4
(list s c o r e
d is t  sc o r e
d is t  s c o r e
d is t  sc o r e
Figure 9. D istribution categories for scoring the subcellular  
distribution pattern o f TR and variants. Scoring examples for 
receptors; all nuclear (4), more nuclear (3), even whole cell (2), more 
cytoplasmic (1), and entirely cytoplasmic (0). Cell examples o f  scores 3? 
1, and 0 above would also be counted as punctate distributions with foci.
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10A. GFP-G121A distributions in WC, CSK, NMIF extractions
■  even/cyto.
□  more nuclear
% ce lls  so
WC CSK NMIF
10B. Percentage of cells with punctate distributions of GFP-G121A 
in WC, CSK, NMIF extractions
WC CSK NMIF
Figure 10. Effects of WC, CSK, and NMIF extractions on GFP-G121A  
distribution. Distribution of GFP-G121A shifts to more cytoplasmic in CSK and 
NMIF extractions (10A). Distribution of GFP-G121A also shifts to more 
punctate/foci distribution in CSK and NMIF extractions (10B).
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GFP-TRp localization shifts to more cytoplasmic with cytoskeletal disruption
GFP-TRp exhibited a more nuclear WC distribution (Figure 8, panels 2a-2b). 
Approximately 70% of cells had a more nuclear distribution scored as 3 or 4. In 
addition, approximately 53% of cells were scored as having punctate distributions. 
These distributions changed dramatically with CSK and NMIF fixations. In CSK 
fixation, only 17% of cells had more nuclear distributions, and in the NMIF fixations, 
only 7% (p<0.001, LR=0.4517) (Figure 11). The presence of punctate distributions 
increased as well to close to 100% in both types of fixations (p<0.0001, LR=0.0069) 
(Figure 11). Once again, the receptor localization shifted to a more cytoplasmic and 
more punctate distribution when the cytoskeleton was removed.
GFP-TRa distribution shifts to more cytoplasmic upon cytoskeletal disruption
As discussed previously, GFP- TR a shuttles between the cytoplasm and the 
nucleus, although it displays an almost completely nuclear distribution pattern. 
Approximately 99% of cells scored had a more nuclear distribution with a score of 4 
or 3 (Figure 8, panel 1). In CSK fixations, this percentage dropped to 58%, and 
dropped further to only 39% in NMIF fixations (p<0.0001, LR=0.0988)(Figurel2, 
panel 1; Figure 13). Foci distributions changed significantly as well, from only 
approximately 15% of cells with GFP- TRa foci distributions in WC fixations to 54% 
and 80% of cells with foci distributions in CSK and NMIF fixations respectively 
(p<0.0001, LR=0.3152)(Figure 13). Once again, the overall shift was towards more 
cytoplasmic and more punctate distributions upon removal of the cytoskeleton.
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11 A. GFP-TRp distributions in WC, CSK, NMIF extractions
■  more nuclear 
□  even/cyto.
% ce l l s  so
WC CSK NMIF
11B. Percentage of cells with punctate/foci distributions of G F P -T R p  
in WC, CSK, N M IF  extractions
NMIF
% cells
CSK
Figure 11. Effects of WC, CSK, NMIF extractions on GFP-TRp. Distribution of 
GFP-TRp changes to more cytoplasmic (11 A) and more punctate/foci (1 IB) with 
CSK and NMIF fixations.
Figure 12. C F P -T R a distributions in NMIF, cytochalasin D, and colchicine 
experiments. Distributions change to more cytoplasmic and more foci with 
NMIF fixations (1 ).and cytochalasin D experiments for actin disruption (2), and 
colchicine experiments for microtubule disruptions (3). Also note with NMIF 
fixatin the removal o f chromatin as evident by reduced D A PI nuclear staining 
(lb).
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13A. GFP-TRa distributions with WC, CSK, NMIF extractions
■  more nuclear 
□  even/cyto.
13B. Percentage of cells with punctate/foci distributions of G F P -T R a  in 
WC, CSK, N M IF  extractions
WC CSK NMIF
Figure 13. Distributions of GFP-TRa in WC, CSK, NMIF extractions.
Distributions of GFP-TRa shift to more cytoplasmic ( 13 A) and more punctate/foci 
(13B) with CSK and NMIF extractions.
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In summary, the general shift for GFP-TRa, GFP-TRp, and GFP-G121A was 
towards a more cytoplasmic and more punctate distribution upon removal of the 
cytoskeleton in NMIF fixations. The CSK fixations resulted in the same shift, but to 
a lesser degree, possibly due to some of the cytoskeleton being extracted during 
fixation, as indicated through YFP-actin and YFP-tubulin controls. Taken together, 
these results indicate that removal of the actin and microtubules does significantly 
effect the location of the receptor in the cell.
CYTOCHALASIN D ACTIN DISRUPTION MAY AFFECT RECEPTOR 
LOCALIZATION
The next set of experiments performed was aimed at selectively disrupting the 
actin filament system in living cells to determine the resulting effects on receptor 
localization. This procedure is less harsh than the previous extraction procedure. It 
involves disrupting a selective element of the cytoskeleton in live cells, and allowing 
time for TR distribution to change accordingly. To do this, the actin disrupting drug 
cytochalasin D was used. Cytochalasin D is a fungal alkaloid which works by 
binding to the (+) end of the filament and causing disassembly at the (-) end of the 
filament. NIH3T3 cells were once again transfected with expression vectors for 
fluorescent protein constructs including YFP-actin, YFP-tubulin, GFP-G121 A, GFP- 
TRa, and GFP-TRp. 24 hours post transfection, the cells were treated with 
cytochalasin D, fixed , and viewed with fluorescence microscopy to determine 
localization patterns. Various concentrations of cytochalasin D were used including
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5pM, lOpM, and 15pM, to determine the most appropriate concentration. 15pM 
produced the most dramatic results, without compromising the integrity of the cell.
YFP-actin controls
To assess the efficiency of actin disruption on the actin cytoskeleton, cells 
were transfected with YFP-actin, and then treated with cytochalasin D, vehicle 
(DMSO) alone, or no treatment. Upon treatment with cytochalasin D, NIH3T3 cells 
should appear more rounded up than their normal spread appearance of NIH3T3 cells, 
possibly with some protrusions from the cytoplasm (Ribiero et al., 1997). 
Depolymerized actin also may accumulate into foci in the cytoplasm. Since the 
majority of YFP-actin had a diffuse whole cell appearance (Figure 5), YFP-actin 
would give a good marker for cell shape and distribution of actin in the cell. There 
were no obvious or significant differences in the cells receiving no treatment and the 
cells treated with DMSO vehicle. However, there was a significant difference in the 
number of cells with a rounded appearance in the 15pM cytochalasin D treatment 
group(p,0.0001, LR=0.1999). A much greater percentage of cells appeared rounded 
after treatment with cytochalasin D (Figure 14).
GFP-G121A, GFP-TRp, and GFP-TRa with cytochalasin D
Having determined the optimal concentration of cytochalasin D, cells were 
then transfected with GFP-G121 A, GFP-TRp, or GFP-TRa, and distributions of these 
receptors in cells treated with cytochalasin D or vehicle were recorded. Larger 
groupings of distribution scores were made, with 4 and 3 being grouped together as
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Vehicle 15 uM cytochalasin D
YFP-actin %
30 uM colchicineVehicle
YFP-tubulin
K * m
Figure 14. The effect of cytochalasin D and colchicine on cell shape. As indicaled by the 
distribution pattern o f YFP-actin and YFP-tubulin, cells round upon treatment with either 15 
uM cytochalasin D or 30 uM colchicine.
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“more nuclear”, and scores of 2, 1, and 0 grouped as “even/cytoplasmic” for GFP- 
G121A and GFP-TRp distributions. For GFP-TRa, a score of 4 was considered “all 
nuclear”, and scores of 3 ,2 , 1, and 0 were grouped together as “some cytoplasmic” .
The distributions of GFP-G121A and GFP-TRa shifted to more cytoplasmic 
distributions upon cytochalasin D treatment (Figure 12, panel 2, Appendix). Both p 
values indicated significant results(p,0.0001,LR=0.0054; p<0.0001, LR^O.4572 
respectively), however, the likelihood ratio for GFP-G121A was poor indicating 
variation among trials. GFP-TRa also shifted towards a significantly more punctate 
distribution upon cytochalasin D treatment as well. The results for GFP-TRp showed 
no significant change in distribution of the receptor between vehicle and cytochalasin 
D experiments (p0.8738, LR=0.0068).
In summary, results suggest the very interesting possibility that there is an 
interaction between the actin cytoskeleton and TRa, but not TRp. However, more 
experiments will be required to unequivocally show this interaction.
DISRUPTION OF MICROTUBULES LEADS TO CHANGES IN RECEPTOR 
LOCALIZATION
The microtubule disrupting drug colchicine was used in the next set of 
experiments to determine the individual role that microtubules may play in the 
nucleocytoplasmic shuttling of TR. Colchicine is derived from a plant and causes 
stabilization of microtubules at low concentrations and depolymerization of 
microtubules at high concentrations through inhibition of microtubule dynamics
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(Lodish et al., 1995). In this case, 30jaM of colchicine was used, according to 
established procedures (Hollingshead, 2001).
YFP-tubulin controls
To determine the efficiency of colchicine in disrupting the microtubule 
network, experiments were performed using YFP-tubulin. If microtubules were being 
disrupted, rounding up of the cells with cytoplasmic blebs protruding from the 
membrane should occur. There were no significant differences in the shape of cells 
treated with vehicle, and cells with no treatments at all. There was a significant 
difference between vehicle treated and colchicine treated cells, with colchicine treated 
slides having a greater percentage of cells with a rounded appearance (Figure 14).
This is evidence that the microtubule disruption with colchicine is effective.
GFP-G121A, GFP-TRp, and GFP-TRa distributions change with colchicine 
disruption o f  microtubules
For colchicine disruption experiments, receptor localizations were once again 
grouped into larger categories. These categories were the same as those for the 
cytochalasin D experiments. In the case of all receptors, distributions changed 
significantly to more cytoplasmic distributions with colchicine treatments (Figure 15; 
Appendix). GFP-TRa also shifted towards a more punctate distribution with 
colchicine treatment (Figure 12, panel 3). GFP-TRp shifted to a less punctate 
distribution, and no significant changes in foci were observed for GFP-G121 A. In 
summary, the results of the microtubule disruption data indicate a more dramatic
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15. Effects of colchicine on receptor localization
% cells 
cytoplasmic
vehicle colchicine
■  GFP-TRa
□  GFP-TRb
□  GFP-G121A
Figure 15. Effects of colchicine on receptor localization. GFP-TRa shifts to more 
cytoplasmic localization (scores 3-0) upon colchicine treatment. GFP-TRp and GFP- 
G121A also shift to more cytoplasmic localizations (scores 2-0) upon colchicine 
treatments.
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change in distributions of the receptors when microtubules are disrupted than when 
actin fdaments are disrupted. Since there was a shift to a more cytoplasmic 
distribution, this suggests a possible role for intact microtubules in nuclear import.
ADDITIONAL DRUG TREATMENT CONTROLS
In light of the data obtained from cytochalasin D and colchicine experiments, 
it became clear that it was necessary to test the specificity o f the respective disrupting 
agents for the different elements of the cytoskeleton. Due to the close association of 
actin and microtubules (Yarm et al, 2001), it was possible that cytochalasin D was 
indirectly causing disruption of the microtubule cytoskeleton, and colchicine was 
indirectly effecting the actin cytoskeleton.
The YFP-tubulin gene template was transfected into cells which were then 
treated with vehicle or cytochalasin D to assess whether the drug disrupted the 
microtubules. The two distribution categories for YFP-tubulin, whole cell 
distribution and mostly cytoplasmic distribution, were used to classify localization. 
There was a difference in distribution between vehicle and cytochalasin D treated 
cells; in drug treated cells YFP-tubulin shifted to more cytoplasmic 
distribution;however the likelihood ratio was poor (Appendix).
Next, YFP-actin was transfected into cells which were then treated with 
colchicine or vehicle to determine if colchicine indirectly affected the actin 
cytoskeleton. Once again, the normal YFP-actin distributions were used as the 
classification categories. There was essentially no difference in distributions between 
vehicle and colchicine treated cells (Appendix).
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These results show that microtubule disruption via colchicine has little to no 
effect on the actin cytoskeleton, and therefore indicate that the results obtained from 
the colchicine disruption experiments are truly due to the disruption of the 
microtubules. On the other hand, cyochalasin D may affect microtubules to a certain 
degree, not just the actin cytoskeleton. This may mean that some part of the actin 
disruption data could actually be due to a disruption of the microtubule cytoskeleton 
as well.
EVIDENCE FOR COLOCALIZATION OF GFP-G121A WITH ACTIN AND 
MICROTUBULES
Studies were also performed to assess whether G121A colocalizes with either 
the actin filaments or the microtubules. G121A was used due to its more cytoplasmic 
localization, which would make it easier to visualize colocalization with elements of 
the cytoplasm. To do this, CFP-G121A was cotransfected with either YFP-tubulin or 
YFP-actin.
Interestingly, in some cells CFP-G121A colocalized with YFP-tubulin and 
YFP-actin (Figure 16). In general, approximately 50% showed some degree of 
colocalization of G121A with either actin or tubulin. In some cells, the colocalization 
was almost complete, however, in others, there was no colocalization. Results were 
not quantified due to the extremely variable results. The variability of results may be 
due to the cotransfection procedure, and the difficulty of finding cells with both 
proteins expressed at nearly the same levels. Clarification of these observations will
YFP-actin CFP-G121A overlay
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YFP-tubulin CFP-G 12IA overlay
Figure 16. Colocalization o f  CFP-G121A and YFP-actin or YFP- 
tubuliin. E xam ples o f  near 100%  colocalization  o f  C FP -G 121A  and Y FP- 
actin or Y FP-tubulin . T his d istribu tions represents only a portion o f  cells 
expressing  both Y FP and C FP constructs.
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involve further experimentation, and possibly the use of antibody stains for the 
cytoskeleton.
HETEROKARYON EXPERIMENTS INDICATE INTACT MICROTUBULES 
NEEDED FOR SHUTTLING TO OCCUR
The above described experiments showed a more cytoplasmic distribution of 
TR when the cytoskeleton was disrupted suggesting that nuclear import may require 
an intact cytoskeleton. Thus, the next set of experiments performed were 
heterokaryon experiments, a classic method for the analysis of nucleocytoplasmic 
shuttling (Spector et al., 1998). This set of experiments was aimed at determining 
whether shuttling of T R a was attenuated if an element of the cytoskeleton was 
disrupted. This would infer a reliance on this cytoskeletal element for shuttling of the 
receptor through the cytoplasm to the NPC. These experiments involved fusing GFP- 
TR a transfected NIH3T3 (mouse) cells with HeLa (human) cells, to determine if 
shuttling of GFP-TRa occurs between the nuclei, in the common cytoplasm. GFP- 
TR a was used because it has a mostly nuclear distribution, although it does shuttle 
rapidly between the cytoplasm and nucleus, thus allowing for easier determination of 
nuclear presence. Heterokaryon slides were treated with vehicle, colchicine, or 
cytochalasin D. If shuttling of the receptor occurs, the receptor should be exported 
from the mouse nuclei, and move through the shared cytoplasm to the human nuclei.
In cells in which it could be determined through Nomarski optics that the 
NIH3T3 and HeLa cells had fused due to the presence of a continuous cytoplasmic 
membrane, localization of the receptor was classified as not shuttling, even shuttling,
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or uneven shuttling where the receptor localization was significantly brighter in the 
NIH3T3 nucleus than in the HeLa nucleus. In vehicle treated slides, all 
heterokaryons observed had shuttling of the receptor to a certain extent. 
Approximately 74% of heterokaryons had uneven shuttling, while about 26% had 
even shuttling. In cytochalasin D treated slides, once again, all heterokaryons 
observed had some degree of shuttling. In colchicine treated slides however, 17 out 
of 22 heterokaryons observed had no shuttling, and 5 heterokaryons had uneven 
shuttling (Figure 17). This suggests that when the microtubules are disrupted, GFP- 
TR a can no longer efficiently shuttle between the cytoplasm and nucleus. These 
findings point to the intriguing possibility that the microtubules are important for 
transport of TRa.
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Figure 17. Heterokaryons treated with colchicine. In heterokaryons( la,b,c) and 
homokaryons (2a,b.,c) treated with colchicine,shuttling of GFP-TRa does not occur between 
transfected mouse and untransfected human nuclei. Normal shuttling is observed in 
heterokaryons treated with vehicle only (3a.b,c). Nomarski optics show the continuous 
cytoplasmic membrane around the nuclei to verify fusion has occured between cells. Nuclei 
were stained with Hoechst to distinguish mouse and human nuclei.
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DISCUSSION
TR is an important nuclear receptor which regulates the effects of the thyroid 
hormone in vertebrates. Because the thyroid hormone itself is involved in so many 
facets of development and homeostasis, TR and its function and activity are important 
areas of research. Even though TR exerts its functions in the nucleus, it is possible 
that an important step in regulation arises from the receptor’s cytoplasmic behavior. 
Since TR is synthesized in the cytoplasm, it must be targeted to, and enter the nucleus 
to perform its functions. Investigation into possible associations of the receptor with 
elements of the cytoskeleton is a step in understanding this cytoplasmic behavior. 
Evidence presented in this thesis suggests a possible role of the microtubules in 
directed transport of TR from the cytoplasm to the nucleus.
IMPORTANCE OF MICROTUBULES IN TR SHUTTLING
The results in this thesis provide evidence of dramatic changes in distributions 
of the receptors that were observed upon microtubule disruption. These results 
indicated changes in localizations for all receptors tested, TRa, TRp, and the 
transactivation mutant G121A. The significance of microtubule disruption on 
receptor localization was confirmed again upon realization that microtubule 
disruption had no effect on the actin cytoskeleton, but the results of the actin 
disruption experiments may in fact be an artifact of partial microtubule disruption.
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The results contained in this thesis provide somewhat inconclusive results as to the 
possibility of interaction of forms of the thyroid hormone receptor with the actin 
cytoskeleton. Colocalization studies suggest some degree of colocalization of actin 
and G121A in some cells, although many cells did not exhibit this pattern. Also, 
GFP-TRa and GFP-G121A had localization changes when the actin cytoskeleton was 
disrupted. Colocalization studies also indicated some degree of colocalization 
between microtubules and G121 A, although the results of these experiments were no 
more conclusive than those for actin colocalization. In situ fractionation experiments 
also indicated a dramatic change in localization of all three receptors upon extraction 
of the cytoskeleton, although in these experiments no distinction could be made 
between actin and microtubules.
If microtubules are in fact important for directed motion of TR through the 
cytoplasm, disruption of the microtubules should lead to slower /less efficient 
movement of the receptor. In this scenario, the kinetics of TR nuclear export would 
not be effected, but entry back into the nucleus would be slowed, or completely 
blocked. This would result in a cytoplasmic accumulation of newly synthesized TR 
and TR exported from the nucleus upon disruption of its locomotion machinery, the 
microtubules. This proposed shift was, in fact observed upon microtubule disruption. 
G121A was expected to yield the most interesting results due to its more cytoplasmic 
localization. It was believed that observation of interaction with elements of the 
cytoskeleton would be more apparent due to its localization. As it turned out, TRa 
proved to have the most dramatic and interesting results due to its primarily nuclear
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localization in normal cells. The shift towards the cytoplasm was more apparent and 
striking upon microtubule disruption.
Perhaps the most intriguing data came from the heterokaryon experiments, in 
which it was apparent that cytoplasmic movement of TRa was hindered upon 
microtubule disruption. This confirms the data suggesting an association between 
microtubules and TR, and provides additional evidence towards a locomotive role of 
the cytoskeleton for TR. This association would not be unexpected, since many other 
nuclear receptors have been shown to utilize the cytoskeleton for movement from the 
cytoplasm to the nucleus (Galigniana et al., 1998; Galigniana et al., 1999; Galigniana 
et al., 2001;Barsoney et al., 1997, Kamimura et al., 1995).
SIGNIFICANCE OF PUNCTATE DISTRIBUTIONS
The significance of the punctate distributions of TR and variants observed in 
many experiments is somewhat mysterious. The general trend upon cytoskeletal 
disruption or removal was towards a more punctate distribution, with foci/aggregates 
in the cytoplasm, but there were exceptions. Aggregate formation has been observed 
in tubulin and actin upon cytoskeletal disruption as well, and appears unrelated to the 
presence of fluorescent protein fusions (Johnston et al., 1998). This may mean that if 
TR is in fact associating with an element of the cytoskeleton, namely the 
microtubules, it may be carried into these cytoplasmic foci by the microtubules.
There is also intriguing research into cytoplasmic formations called 
aggresomes. These structures appear as accumulations of aggregated protein 
throughout the cytoplasm, which gradually over time progress to a few bright foci at
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the site of the MTOCs (Garcia-Mata et ah, 2002; Shimohata et al., 2002; Ma and 
Lindquist, 2001; Garcia-Mata et al., 1999). It is believed that aggresomes form due to 
overexpression of protein, or misfolded proteins. More specifically, they form when 
the existing pathway for protein degradation is overloaded (Johnston et al., 1998). 
Transport of aggregated protein occurs via microtubules and the retrograde motor 
protein dynein to cause accumulation at the MTOCs (Johnston et al., 1998). Upon 
disruption of the microtubules, it has been shown that aggresomes disperse into 
smaller aggregations throughout the cytoplasm, or become perinuclear in distribution 
(Shimohata et al., 2002; Johnston et al., 1998).
It is possible that the forms of TR studied are forming aggresomes in some 
cells. There has been shown to be a cage of vimentin, which is a protein that makes 
up intermediate filaments, surrounding aggresomes in the cytoplasm (Johnston et 
al.,1998; Shimohata et al., 2002; Garcia-Mata et al., 2002). If the foci seen for TR are 
in fact aggresomes, this may explain the observation that vimentin colocalizes with 
G121A in some instances (Hollingshead , 2001). Colocalization with vimentin 
occured where G121A had accumulated in foci or aggregates. The colocalization 
observed could be due to the formation of aggresomes. It is also possible that this 
colocalization was an artifact due to the close association of microtubules and 
intermediate filaments, and may only indicate a colocalization with the microtubules. 
As discussed earlier, there are no known motor proteins for intermediate filaments, so 
an association of TR with intermediate filaments for the purpose of locomotion within 
the cell would be unlikely. It is more likely that the association is due to aggresome 
formation, or close association of vimentin and TR with microtubules.
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If aggresomes are forming, it is unclear as to why this phenomenon is 
occurring. It has been demonstrated for other proteins that the GFP tag is not 
responsible for aggregation of proteins (Johnston et al., 1998). It is possible that 
since G121A is a mutated form of TR(3, the protein’s ability to fold correctly is 
somewhat hindered, and more of the protein is sent for degradation and to form 
aggresomes. It does appear that a greater percentage of G121A accumulates in foci 
or aggregates compared with either TRa or TRp. Misfolding of G121A is considered 
a somewhat unlikely explaination, however, since prior experiments have shown 
normal functioning of G121A with respect to DNA binding and hormone binding 
(Nelson et al., 1993). If misfolding was occurring, it seems that these functions 
should be hindered as well. A possibility does exist that the receptors are simply 
being extremely overexpressed in the experiments presented in this thesis, and this 
overexpression is resulting in recruitment of excess TR to aggresomes. Since G121A 
has a more cytoplasmic distribution in general, more of the overexpressed receptor 
would be available for aggregation than, for example, TRa which is almost entirely 
nuclear.
To determine the nature of foci and aggregates of TR, many other experiments 
would have to be performed. It would be helpful to observe live cells with a confocal 
microscope over a period of time. This would allow one to visualize a progression 
from many cytoplasmic foci to large aggresomes at the site of the MTOCs. If this 
progression was confirmed, microtubule disrupting drugs would be used to determine 
if they caused disruption and dispersal of the large aggresomes into smaller more 
dispersed aggregates. Additional studies using vimentin-specific antibodies should
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also be employed to see if the characteristic vimentin cage can by visualized 
surrounding the putative TR aggresome. All of these experiments would help to 
determine if the aggregates of TR are in fact aggresomes.
FUTURE EXPERIMENTS
A variety of experiments could be performed to verify the results obtained in 
this thesis and to determine if TRs are in fact associating directly with the 
microtubules for the purpose of transport through the cytoplasm. One such 
experiment is to clarify the colocalization patterns with actin, microtubules, and 
intermediate filaments by using antibody staining of the cytoskeletal filaments, along 
with very specific scoring categories. Visualization of the cytoskeleton in this 
manner may provide a clearer view of the actual filament systems than with 
transfection experiments, due to the problem of inefficient incorporation of the YFP- 
actin and YFP-tubulin into the filament networks inherent in the transfection method.
Another set of experiments could involve visualization of receptor movement 
in live cells. An advantage of the transfection methods with fluorescent protein 
constructs used in this thesis is that the data provide the groundwork for work on live 
cells, since antibody staining can not be used for live cell imaging. In live cells, it 
may be possible to compare the rate o f cytoplasmic accumulation of TR upon 
cytoskeletal disruption to the normal accumulation in intact cells. It is also possible 
to use fluorescence recovery after photobleaching (FRAP) to photobleach the nucleus 
of cells transfected with GFP-TRa or GFP-TRp. This would allow for observation of 
the rate of return of fluorescence to the nucleus over time in normal and cytoskeletal
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disrupted cells. Experiments using heterokaryons and homokaryons could also be 
developed in a similar manner.
Additionally, it may be possible to biochemically assess the interaction 
between microtubules and TR. Microtubules can be induced to polymerize in vitro 
using Taxol. Microtubules could be incubated with combinations of TR, importins, 
cell lysates, and other proteins, and then the microtubule fractions of the mixture 
analyzed through SDS-PAGE and Western blotting. This would allow investigation 
as to whether TR does biochemically interact with the microtubules, and if so, what 
other factors are necessary for the interaction. This type of experiment may be 
difficult, due to the uncertainty of what factors may bridge the interaction of TR with 
the microtubules.
CONCLUSIONS
The role of the cytoskeleton in the cytoplasmic shuttling of TR has not been 
investigated until now. Since so many other individual proteins related to TR have 
been shown to rely on the cytoskeleton for transport in the cytoplasm, it seems 
plausible that TR would utilize a similar mechanism. Examples of proteins utilizing a 
similar mechanism are the glucocorticoid receptor, the vitamin D receptor, and 
parathyroid hormone related protein (Galigniana et al., 1998; Galigniana et al., 1999; 
Galigniana et al., 2001; Barsony et al., 1997, Kamimura et al., 1995; Lam et al.,
2002). All o f these proteins rely specifically on the microtubules for directed 
transport through the cytoplasm. The results of this thesis suggest a possible role for 
microtubules in movement of TR through the cytoplasm to the nucleus, while actin
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does not appear to be involved in transport. Association with microtubules may 
prove to be another step involved in the regulation of TR nuclear import and 
subsequent regulation of T3 responsive genes which had yet to be identified. Since 
the thyroid hormone and its receptor affect so many processes in vertebrates, any 
information on the functioning o f TR helps us to understand the processes which TR 
controls. Elucidation of the functions of TR may lead to more understanding of how 
mutant forms of TR cause disease in humans, and possibly lead to better treatments 
for these diseases in the future.
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Cell counts for all experiments 
NMIF EXPERIMENTS
GFP-TRa W C/CSK/NMIF
diff foci more nuc. score 4,3 even/cyt.(score 2,1,0)
w c 85 15 100 0
CSK 44 36 59 41
NMIF 18 82 32 68
WC 83 17 96 4
CSK 38 62 63 37
NMIF 24 76 51 49
WC 88 12 100 0
CSK 37 63 53 47
NMIF 18 82 34 66
p<0.0001, LR=0.0988 p<0.0001, LR=0.3152
GFP-TRb W C/CSK/NMI p
diff foci more nuc. [score 4,3) even/cyt. (score 2,1,0)
WC 50 50 82 18
CSK 0 100 12 88
NMIF 0 100 9 91
WC 49 51 66 34
CSK 0 100 20 80
NMIF 0 100 9 91
WC 43 57 61 39
CSK 0 100 19 81
NMIF 4 96 3 97
p<0.001, LR=0.4517 p<0.0001, LR=0.0069
GFP-G121A WC/CSK/N MIF
diff foci more nuc (score 4,3) even/cyt (score 2,1,0)
WC 34 4 17 21
CSK 2 34 1 35
NMIF 1 12 1 12
WC 73 28 51 50
CSK 5 19 0 24
NMIF 2 30 1 31
WC 70 30 33 67
CSK 6 24 0 30
NMIF 3 27 0 30
p<0.0001, LR=0.0329 p<0.0001, LR=0.4987
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YFP-tubulin WC/CSK/N MIF
entire cell not in nuc total cells % exp
WC 22 78 100 44
CSK 27 73 100 8
NMIF 7 2 100 2
WC 27 73 100 32
CSK 23 77 100 14
NMIF 3 7 100 3
WC 31 69 100 45
CSK 38 62 100 11
NMIF 10 2 100 1
p=0.0003, LR=0.1149 p<0.0001, LR=0.1695
YFP-actin W C/CSK/NM
fil diff foci total cells # exp
WC 23 63 14 224 32
CSK 0 0 0 100 4
NMIF 0 9 26 219 1
WC 24 70 6 211 26
CSK 75 11 14 201 5
NMIF 7 17 19 206 2
WC 9 75 16 100 14
CSK 2 14 84 100 10
NMIF 5 21 74 100 1
p<0.0001 ,LR=0.0006 p<0.0001, LR=0.3145
ACTIN DISRUPTION EXPERIMENTS 72
YFP-actin c y t o - D __________  YFP-tubulin cyto-D
rounded spread whole cell mostly cyto
norm 87 211 DMSO 48 52
DMSO 47 67 15uM CD 45 57
15uM CD 172 73
DMSO 74 26
norm 30 42 15uM CD 42 58
DMSO 47 76
15uM CD 187 64 DMSO 77 24
15 uM CD 46 59
norm 43 67
DMSO 43 57 DMSO 86 20
15uM CD 124 25 15uM CD 45 68
norm /DM SO:p=0.1072LR=0.1934 p<0.0001,LR=0.0003
DMSO/CD:p<O.OOQ1 ,LR=0.1999
GFP-TRa cyto-D
diff foci all nuc.(4) some cyt(3,2,1,0)
norm 92 18 69 31
DMSO 102 15 98 19
15 uM CD 72 30 62 45
norm 75 30 74 31
DMSO 40 15 38 17
15 uM CD 53 49 53 49
norm 36 11 36 11
DMSO 84 21 83 22
15 uM CD 67 35 57 45
p<0.0001, LR=0.8132 p<0.0001, LR=0.4572
GFP-TRb cyto-D
diff foci some nuc(4,3) even/cyt.(2,1,0)
norm 21 41 28 34
DMSO 27 102 48 81
15 uM CD 8 68 40 36
norm
DMSO 3 78 18 63
15uM CD 20 90 22 88
norm
DMSO 3 48 18 33
15uM CD 10 70 14 66
p=0.3141, LR=0.0006 p<0.8738, LR=0.0068
GFP-G121A cyto-D
more nuc (4,3) even/cyt(2,1,0)
DMSO 100 117
15uM CD 18 200
DMSO 52 49
15uMCD 30 73
DMSO 55 61
15uM CD 17 106
p<0.0001, LR=0.0054
M ICROTUBULE DISRUPTION EXPERIMENTS 74
YFP-tubulin colchicine YFP-actin colchicine
rounded spread filaments diffuse foci
normal 16 84 DMSO 9 85 6
DMSO 14 86 30uM colc 8 84 8
30uM colc 84 16
DMSO 7 89 4
normal 8 92 30uM colc 9 89 2
DMSO 22 78
30uM colc 86 14 DMSO 12 83 5
30uM colc 7 90 3
normal 25 75 p=0.7709, LR=0.5781
DMSO 24 76
30uM colc 90 10
norm/DMSO: p=0.2416, LR=0.0341
DMSO/Colch: p<0.0001,LR=0.7630
GFP-Tra colchicine
all nuc(4) some cyto (3,2,1,0) Diffuse Foci
DMSO 83 17 83 17
30uM colc 65 35 64 36
DMSO 82 18 84 16
30uMcolc 54 46 61 39
DMSO 78 22 81 19
30uM colc 62 38 64 36
p<0.0001, LR=0.4329 p<0.0001, LR=0.7752
GFP-TRb colchicine
more nuc (4,3) even/cyt. (2,1,0) diffuse foci
DMSO 59 41 43 57
30uM colc 26 74 65 35
DMSO 58 42 46 54
30uM colc 30 70 61 39
DMSO 49 51 48 52
30uM colc 33 67 59 41
p<0.0001 ,LR=0.1977 p<0.0001, LR=0.5247
GFP-G121a
more nuc (4,3) even/cyto(2,1,0)
DMSO 61 48
30uM colc 5 95
DMSO 49 51
30uM colc 16 84
DMSO 48 52
30uM colc 11 89
p<0.0001, LR=0.0200
HETEROKARYON EXPERIMENTS
with colchicine
shuttling (even) shuttling (uneven) not shuttling
DMSO 6 14 0
colc 0 5 17
with cytochalasin D
shuttling (even) shuttling (uneven) not shuttling
DMSO 5 15 0
Cyto-D 4 17 0
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